Astera Labs (NASDAQ:ALAB) Cut to “Hold” at Wall Street Zen

Wall Street Zen lowered shares of Astera Labs (NASDAQ:ALAB) from a buy rating to a hold rating in a research report sent to investors on Friday morning.

A number of other analysts have also recently commented on the company. Jefferies Financial Group upped their price objective on Astera Labs from $95.00 to $130.00 and gave the company a “buy” rating in a research report on Tuesday, July 22nd. Barclays reaffirmed an “overweight” rating and set a $155.00 price target (up previously from $75.00) on shares of Astera Labs in a research report on Thursday, August 7th. Northland Capmk cut shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 22nd. Cowen started coverage on shares of Astera Labs in a research report on Tuesday, September 30th. They set a “hold” rating for the company. Finally, Susquehanna upped their target price on shares of Astera Labs from $80.00 to $125.00 and gave the company a “neutral” rating in a report on Thursday, August 7th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $159.83.

Astera Labs Stock Down 4.2%

Shares of ALAB stock opened at $200.74 on Friday. The company has a 50 day moving average price of $189.83 and a 200-day moving average price of $119.85. Astera Labs has a 52 week low of $47.13 and a 52 week high of $262.90. The firm has a market capitalization of $33.37 billion, a PE ratio of 358.46, a P/E/G ratio of 5.09 and a beta of 1.43.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The company had revenue of $191.93 million for the quarter, compared to analysts’ expectations of $172.46 million. During the same quarter last year, the company posted $0.13 earnings per share. The firm’s quarterly revenue was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Analysts anticipate that Astera Labs will post 0.34 earnings per share for the current year.

Insider Transactions at Astera Labs

In other news, COO Sanjay Gajendra sold 280,000 shares of the company’s stock in a transaction that occurred on Thursday, August 7th. The stock was sold at an average price of $170.02, for a total transaction of $47,605,600.00. Following the sale, the chief operating officer directly owned 5,525,545 shares of the company’s stock, valued at $939,453,160.90. This represents a 4.82% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jitendra Mohan sold 152,517 shares of the stock in a transaction that occurred on Thursday, August 7th. The shares were sold at an average price of $170.33, for a total value of $25,978,220.61. Following the transaction, the chief executive officer owned 450,001 shares of the company’s stock, valued at $76,648,670.33. This represents a 25.31% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,492,036 shares of company stock valued at $232,607,552 in the last ninety days. Corporate insiders own 12.50% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

Several institutional investors have recently bought and sold shares of ALAB. Oliver Lagore Vanvalin Investment Group purchased a new position in shares of Astera Labs in the 2nd quarter worth $29,000. Bernard Wealth Management Corp. bought a new position in shares of Astera Labs in the 2nd quarter valued at about $36,000. Clearstead Trust LLC grew its position in Astera Labs by 46,100.0% in the second quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock worth $42,000 after acquiring an additional 461 shares in the last quarter. Advisors Asset Management Inc. increased its stake in Astera Labs by 68.6% during the second quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock worth $43,000 after acquiring an additional 194 shares during the last quarter. Finally, Manchester Capital Management LLC raised its position in Astera Labs by 141.5% during the second quarter. Manchester Capital Management LLC now owns 483 shares of the company’s stock valued at $44,000 after purchasing an additional 283 shares during the period. Institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.